Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer
- 30 April 2007
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 43 (6), 1101-1107
- https://doi.org/10.1016/j.ejca.2007.01.029
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The predictive value of apoptosis protease‐activating factor 1 in rectal tumors treated with preoperative, high‐dose‐rate brachytherapyCancer, 2005
- Role of Apaf‐1, a key regulator of apoptosis, in melanoma progression and chemoresistanceExperimental Dermatology, 2005
- Decreased expression of Apaf-1 with progression of melanomaPigment Cell Research, 2005
- Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinomaOncogene, 2004
- Allelic Imbalance of 12q22–23 Associated with APAF-1 Locus Correlates with Poor Disease Outcome in Cutaneous MelanomaCancer Research, 2004
- Tissue microarrays in drug discoveryNature Reviews Drug Discovery, 2003
- The regulation of APAF1 expression during development and tumourigenesis.Apoptosis, 2002
- Human Genome and Diseases:¶Apaf1 in developmental apoptosis and cancer: how many ways to die?Cellular and Molecular Life Sciences, 2001
- Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian DevelopmentCell, 1998
- Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain DevelopmentCell, 1998